There are 1105 resources available
336MO - A phase II single-arm, open-label trial of pamiparib in metastatic castration-resistant prostate cancer (mCRPC) patients with deleterious germline or somatic BRCA1/2 alterations or homologous recombination deficiency (HRD): Interim analysis of efficacy and safety results
Presenter: Diwei Zhao
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Biparatopic antibodies targeting FGFR2 for the treatment of cholangiocarcinoma and gastric cancer
Presenter: William Sellers
Session: Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle
Resources:
Slides
Webcast
Liposarcoma
Presenter: Herbert Ho Fung Loong
Session: Focus on treatment of specific sarcoma types
Resources:
Slides
Webcast
337MO - Efficacy and safety of rezvilutamide (Rez) plus androgen-deprivation therapy (ADT) in patients with high-volume, metastatic, hormone-sensitive prostate cancer (mHSPC) aged ≤64, 65–74, and ≥75 years: Post-hoc analysis of randomized phase III CHART trial
Presenter: Xuefeng Qiu
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
CLAUDIN-6 CAR-T + mRNA vaccine
Presenter: John Haanen
Session: Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle
Resources:
Slides
Webcast
Improving the model of care for cancer survivors
Presenter: Michael Jefford
Session: Cancer survivorship: The end is the start
Resources:
Slides
Webcast
Chondrosarcoma
Presenter: Elizabeth Connolly
Session: Focus on treatment of specific sarcoma types
Resources:
Slides
Webcast
Q&A and discussion
Session: Cancer survivorship: The end is the start
Resources:
Webcast
Invited Discussant 335MO, 336MO and 337MO
Presenter: Elena Castro
Session: Mini Oral session: Genitourinary tumours
Resources:
Slides
Webcast
Alveolar soft part sarcoma (ASPS)
Presenter: Silvia Stacchiotti
Session: Focus on treatment of specific sarcoma types
Resources:
Slides
Webcast